Literature DB >> 23523226

A comparative study of 1% silver sulphadiazine (Flammazine®) versus an enzyme alginogel (Flaminal®) in the treatment of partial thickness burns.

Henk Hoeksema1, David Vandekerckhove, Jozef Verbelen, Alexander Heyneman, Stan Monstrey.   

Abstract

INTRODUCTION: In the conservative treatment of burns, rapid wound healing is desirable to obtain good a esthetic and functional results. The aim of this study was to compare the efficacy of 1% Silversulfadiazine (SSD/Flammazine(®)) and an enzyme alginogel (Flaminal(®) or Flaminal(®) Forte) on the healing of superficial and intermediate partial thickness burns.
METHODS: In this retrospective cohort study comparable burn wounds treated with Flaminal(®) or with 1% SSD were included. Outcome parameters included: length of hospital stay, bacterial burden and time to wound closure. Significance was tested using SPSS package.
RESULTS: 44 wounds in the Flaminal(®) group, and 39 wounds in the 1% SSD group were included. Wounds treated with Flaminal(®) showed a significantly higher bacterial load (p=0.024) and contained significantly more bacterial species (p=0.010) but showed a significantly shorter healing time of 17 vs. 24 days (p<0.0001).
CONCLUSION: A significantly shorter healing time was demonstrated in partial thickness burn wounds treated with Flaminal(®) versus 1% SSD, which may lead to a shorter length of hospital stay and better scar quality. The possibility of accurate burn depth assessment and the results in this study corroborate the change in treatment protocol made in the year 2000 when we switched from 1% SSD to Flaminal(®).
Copyright © 2013 Elsevier Ltd and ISBI. All rights reserved.

Entities:  

Keywords:  Burn wounds; Enzyme alginogel; Flaminal(®); Healing time; Scar; Silver sulphadiazine

Mesh:

Substances:

Year:  2013        PMID: 23523226     DOI: 10.1016/j.burns.2012.12.019

Source DB:  PubMed          Journal:  Burns        ISSN: 0305-4179            Impact factor:   2.744


  7 in total

1.  Ciprofloxacin-lidocaine-based hydrogel: development, characterization, and in vivo evaluation in a second-degree burn model.

Authors:  María Florencia Sanchez; Susana Andrea Breda; Elio Andrés Soria; Luis Ignacio Tártara; Rubén Hilario Manzo; María Eugenia Olivera
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

Review 2.  The use of hydrogen peroxide in the treatment of burn wound infection: a systematic review, and survey of current clinical practice in the United Kingdom.

Authors:  Toni Huw Mihailidis
Journal:  Int J Burns Trauma       Date:  2020-04-15

3.  Long-term quality of life and cost-effectiveness of treatment of partial thickness burns: A randomized controlled trial comparing enzyme alginogel vs silver sulfadiazine (FLAM study).

Authors:  Zjir M Rashaan; Pieta Krijnen; Kelly Aa Kwa; Margriet E van Baar; Roelf S Breederveld; M Elske van den Akker-van Marle
Journal:  Wound Repair Regen       Date:  2020-02-11       Impact factor: 3.617

4.  Flaminal® versus Flamazine® in the treatment of partial thickness burns: A randomized controlled trial on clinical effectiveness and scar quality (FLAM study).

Authors:  Zjir M Rashaan; Pieta Krijnen; Kelly A A Kwa; Cornelis H van der Vlies; Inger B Schipper; Roelf S Breederveld
Journal:  Wound Repair Regen       Date:  2019-02-11       Impact factor: 3.617

5.  Ionic complexation improves wound healing in deep second-degree burns and reduces in-vitro ciprofloxacin cytotoxicity in fibroblasts.

Authors:  María Florencia Sanchez; María Laura Guzman; Jesica Flores-Martín; Mariano Cruz Del Puerto; Carlos Laino; Elio Andrés Soria; Ana Carolina Donadio; Susana Genti-Raimondi; María Eugenia Olivera
Journal:  Sci Rep       Date:  2022-09-26       Impact factor: 4.996

6.  Clinical effectiveness, quality of life and cost-effectiveness of Flaminal® versus Flamazine® in the treatment of partial thickness burns: study protocol for a randomized controlled trial.

Authors:  Zjir M Rashaan; Pieta Krijnen; M Elske van den Akker-van Marle; Margriet E van Baar; Adrianus F P Vloemans; Jan Dokter; Fenike R H Tempelman; Cees H van der Vlies; Roelf S Breederveld
Journal:  Trials       Date:  2016-03-05       Impact factor: 2.279

7.  Silver sulfadiazine nanosuspension-loaded thermosensitive hydrogel as a topical antibacterial agent.

Authors:  Xiaoya Liu; Hui Gan; Chaoran Hu; Wenzhong Sun; Xiaoxia Zhu; Zhiyun Meng; Ruolan Gu; Zhuona Wu; Guifang Dou
Journal:  Int J Nanomedicine       Date:  2018-12-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.